THE LONG VIEW

Bottom Line Up Front: The absence of unified, enforceable AI governance in healthcare is creating systemic risks to patient safety, equity, and trust—particularly in middle-income countries—despite growing regulatory alignment on risk-based frameworks [Yılmaz, 2026]. Threat Identification: The core threat lies in the misalignment between high-level ethical principles (e.g., autonomy, justice) and their operationalization in AI systems, leading to opaque decision-making, biased algorithms, and unclear accountability across developers, clinicians, and institutions [Yılmaz, 2026]. Proprietary 'black box' models exacerbate these risks by limiting transparency and auditability. Probability Assessment: High likelihood within 2026–2028, as AI adoption accelerates in clinical settings while regulatory enforcement lags, especially in regions like Türkiye where implementation capacity remains limited despite legal frameworks such as Law No. 6698 [Yılmaz, 2026]. The FDA’s 2026 guidance and EU AI Act represent progress but lack harmonized enforcement mechanisms. Impact Analysis: Unchecked, this could result in widespread diagnostic errors, health inequities, and erosion of clinician and patient trust in AI tools. Sepsis prediction models with poor interpretability, for example, may lead to delayed interventions or over-reliance, endangering patient outcomes [Yılmaz, 2026]. The impact is amplified in resource-constrained settings with weaker oversight infrastructure. Recommended Actions: 1) Adopt integrated lifecycle governance models that mandate transparency, human-in-the-loop oversight, and equity audits; 2) Strengthen cross-jurisdictional regulatory harmonization, especially for medical AI deployed globally; 3) Fund empirical studies on real-world AI performance and governance efficacy in diverse healthcare systems [Yılmaz, 2026]. Confidence Matrix: - Threat Identification: High confidence (supported by multiple regulatory and case-based analyses) - Probability Assessment: Moderate to high confidence (based on current regulatory timelines and adoption trends) - Impact Analysis: High confidence (grounded in documented risks of algorithmic bias and accountability gaps) - Recommended Actions: Moderate confidence (dependent on political will and institutional capacity, especially in middle-income nations) [Yılmaz, 2026].